Pharma-Bio Serv (PBSV) Projected to Post Quarterly Earnings on Monday

Pharma-Bio Serv (OTCMKTS:PBSV) is expected to be posting its resultson Monday, June 15th. Analysts expect Pharma-Bio Serv to post earnings of $0.03 per share and revenue of $2.50 million for the quarter.

Pharma-Bio Serv (OTCMKTS:PBSV) last released its earnings results on Tuesday, March 17th. The company reported $1.43 earnings per share for the quarter, beating the consensus estimate of $0.02 by $1.41. The company had revenue of $2.30 million for the quarter, compared to analysts’ expectations of $2.70 million. Pharma-Bio Serv had a negative return on equity of 0.66% and a negative net margin of 0.86%.

Pharma-Bio Serv Stock Performance

Shares of OTCMKTS PBSV opened at $0.53 on Monday. The stock has a market cap of $12.03 million, a price-to-earnings ratio of -52.54 and a beta of 0.64. The business has a 50 day simple moving average of $0.53 and a 200 day simple moving average of $0.54. Pharma-Bio Serv has a 52 week low of $0.43 and a 52 week high of $1.36.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.